996 Combination therapy of peginterferon alfa-2A (40KD) (PEGASYS(R)) and ribavirin (COPEGUS(R)) significantly enhance sustained virological and biochemical response rate in chronic hepatitis C genotype 4 patients in Saudi Arabia
- 31 December 2003
- journal article
- abstracts
- Published by Elsevier in Hepatology
- Vol. 38, 636
- https://doi.org/10.1016/s0270-9139(03)81034-0